deuterium has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrastia, CD; Casperson, SL; Dillon, EL; Paddon-Jones, D; Sanford, AP; Sheffield-Moore, M; Sinha, S; Urban, RJ; Volpi, E; Wolfe, RR | 1 |
| Aastveit, TE; Børretzen, B; Dornish, JM; Juul, ME; Larsen, RO; Nesland, JM; Oftebro, R; Pettersen, EO; Rofstad, EK | 1 |
2 other study(ies) available for deuterium and Ovarian Neoplasms
| Article | Year |
|---|---|
Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy.
Topics: Amino Acids; Blood Chemical Analysis; Cytokines; Deuterium; Female; Humans; Inflammation; Middle Aged; Muscle Proteins; NF-kappa B; Ovarian Neoplasms; Phenylalanine | 2007 |
Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Benzylidene Compounds; Cell Division; Deuterium; Dose-Response Relationship, Drug; Female; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Necrosis; Neoplasm Proteins; Neoplasm Transplantation; Ovarian Neoplasms; Transplantation, Heterologous | 1993 |